Brown fat lipoatrophy and increased visceral adiposity through a concerted adipocytokines overexpression induces vascular insulin resistance and dysfunction

Endocrinology

Volumn 153, Issue 3, 2012, Pages 1242-1255

  Gómez Hernández, Almudena ^a,b   Otero, Yolanda F ^a,b   De Las Heras, Natalia ^a,c   Escribano, Óscar ^a,b   Cachofeiro, Victoria ^a,c   Lahera, Vicente ^a,c   Benito, Manuel ^a,b  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c Spanish Network of Cardiovascular Research ^*  (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LEPTIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; TUMOR NECROSIS FACTOR ALPHA;

ABDOMINAL OBESITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; BODY WEIGHT; BROWN ADIPOSE TISSUE; CONTROLLED STUDY; GLUCOSE TOLERANCE; HYPERGLYCEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPOATROPHY; LIVER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKELETAL MUSCLE; WHITE ADIPOSE TISSUE;

ADIPOKINES; ADIPOSE TISSUE, BROWN; ANIMALS; CYTOKINES; DIABETES MELLITUS; GENE EXPRESSION REGULATION; GLUCOSE TOLERANCE TEST; INFLAMMATION; INSULIN; INSULIN RESISTANCE; LIPODYSTROPHY, CONGENITAL GENERALIZED; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; NF-KAPPA B; OXIDATIVE STRESS; RECEPTOR, INSULIN; SIGNAL TRANSDUCTION; SUPEROXIDES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84857420142     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2011-1765     Document Type: Article

References (56)

1. Lazar MA 2005 How obesity causes diabetes: not a tall tale. Science 307:373-375 (Pubitemid 40139971)
2. Aldhahi W, Hamdy O 2003 Adipokines, inflammation, and the endothelium in diabetes. Curr Diab Rep 3:293-298 (Pubitemid 38906785)
3. Ronti T, Lupattelli G, Mannarino E 2006 The endocrine function of adipose tissue: an update. Clin Endocrinol (Oxf) 64:355-365
4. Rosen ED, Spiegelman BM 2006 Adipocytes as regulators of energy balance and glucose homeostasis. Nature 444:847-853 (Pubitemid 46024991)
5. Cypess AM, Lehman S, Williams G, Tal I, Rodman D, Goldfine AB, Kuo FC, Palmer EL, Tseng YH, Doria A, Kolodny GM, Kahn CR 2009 Identification and importance of brown adipose tissue in adult humans. N Engl J Med 360:1509-1517
6. Farmer SR 2008 Brown fat and skeletal muscle: unlike cousins? Cell 134:726-727
7. Almind K, Manieri M, Sivitz WI, Cinti S, Kahn CR 2007 Ectopic brown adipose tissue in muscle provides a mechanism for differences in risk of metabolic syndrome in mice. Proc Natl Acad Sci USA 104:2366-2371 (Pubitemid 46391403)
8. Mattson MP 2010 Perspective: Does brown fat protect against diseases of aging? Ageing Res Rev 9:69-76
9. Ghorbani M, Claus TH, Himms-Hagen J 1997 Hypertrophy of brown adipocytes in brown and white adipose tissues and reversal of diet-induced obesity in rats treated with a β3-adrenoceptor agonist. J. Biochem Pharmacol 54:121-131. (Pubitemid 27353229)
10. Guerra C, Koza RA, Yamashita H, Walsh K, Kozak LP 1998 Emergence of brown adipocytes in white fat in mice is under genetic control. Effects on body weight and adiposity. J Clin Invest 102: 412-420 (Pubitemid 28335201)
11. Aquila H, Link TA, Klingenberg M 1985 The uncoupling protein from brown fat mitochondria is related to the mitochondrial ADP/ ATP carrier. Analysis of sequence homologies and of folding of the protein in the membrane. EMBO J 4:2369-2376
12. Kontani Y, Wang Y, Kimura K, Inokuma KI, Saito M, Suzuki-Miura T, Wang Z, Sato Y, Mori N, Yamashita H 2005 UCP1 deficiency increases susceptibility to diet-induced obesity with age. Aging Cell 4:147-155 (Pubitemid 41602748)
13. Hansen JB, Kristiansen K 2006 Regulatory circuits controlling white versus brown adipocyte differentiation. Biochem J 398:153-168 (Pubitemid 44338472)
14. Phillips LK, Prins JB 2008 The link between abdominal obesity and the metabolic syndrome. Curr Hypertens Rep 10:156-164
15. Guerra C, Navarro P, Valverde AM, Arribas M, Brüning J, Kozak LP, Kahn CR, Benito M 2001 Brown adipose tissue-specific insulin receptor knockout shows diabetic phenotype without insulin resistance. J Clin Invest 108:1205-1213 (Pubitemid 32995379)
16. Escribano O, Guillén C, Nevado C, Gómez-Hernández A, Kahn CR, Benito M 2009 β-Cell hyperplasia induced by hepatic insulin resistance: role of a liver-pancreatic endocrine axis through insulin receptor a isoform. Diabetes 58:820-828
17. Lund DD, Faraci FM, Miller Jr FJ, Heistad DD 2000 Gene transfer of endothelial nitric oxide synthase improves relaxation of carotid arteries from diabetic rabbits. Circulation 101:1027-1033 (Pubitemid 30131706)
18. Lowell BB, S-Susulic V, Hamann A, Lawitts JA, Himms-Hagen J, Boyer BB, Kozak LP, Flier JS 1993 Development of obesity in transgenic mice after genetic ablation of brown adipose tissue. Nature 366:740-742
19. Shimomura I, Bashmakov Y, Horton JD 1999 Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus. J Biol Chem 274:30028-30032
20. Almond RE, Enser M 1984 A histochemical and morphological study of skeletal muscle from obese hyperglycaemic ob/ob mice. Diabetologia 27:407-413 (Pubitemid 14044467)
21. Shoelson SE, Herrero L, Naaz A 2007 Obesity, inflammation, and insulin resistance. Gastroenterology 132:2169-2180 (Pubitemid 46693756)
22. Adams 2nd JM, Pratipanawatr T, Berria R, Wang E, DeFronzo RA, Sullards MC, Mandarino LJ 2004 Ceramide content is increased in skeletal muscle from obese insulin-resistant humans. Diabetes 53: 25-31 (Pubitemid 38044694)
23. Rask-Madsen C, Li Q, Freund B, Feather D, Abramov R, Wu IH, Chen K, Yamamoto-Hiraoka J, Goldenbogen J, Sotiropoulos KB, Clermont A, Geraldes P, Dall'Osso C, Wagers AJ, Huang PL, Rekhter M, Scalia R, Kahn CR, King GL 2010 Loss of insulin signaling in vascular endothelial cells accelerates atherosclerosis in apolipoprotein E null mice. Cell Metab 11:379-389
24. Shoelson SE, Lee J, Goldfine AB 2006 Inflammation and insulin resistance. J Clin Invest 116:1793-1801 (Pubitemid 44033299)
25. Elmarakby AA, Imig JD 2010 Obesity is the major contributor to vascular dysfunction and inflammation in high-fat diet hypertensive rats. Clin Sci (Lond) 118:291-301
26. Horrillo R, González-Périz A, Martínez-Clemente M, López-Parra M, Ferré N, Titos E, Morán-Salvador E, Deulofeu R, Arroyo V, Clària J 2010 5-lipoxygenase activating protein signals adipose tissue inflammation and lipid dysfunction in experimental obesity. J Immunol 184:3978-3987
27. Montague CT, O'Rahilly S 2000 The perils of portliness: causes and consequences of visceral adiposity. Diabetes 49:883-888 (Pubitemid 30349408)
28. Kern PA, Ranganathan S, Li C, Wood L, Ranganathan GP 2001 A dipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 280:E745-E751
29. Marett A 2003 Molecular mechanisms of inflammation in obesity-linked insulin resistance. Int J Obesity 27:S46-S48
30. Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, Marks JS 2003 Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 289:76-79 (Pubitemid 36026281)
31. Bachmanov AA, Reed DR, Tordoff MG, Price RA, Beauchamp GK 2001 Nutrient preference and diet-induced adiposity in C57BL/6ByJ and 129P3/J mice. Physiol Behav 72:603-613 (Pubitemid 32244425)
32. Soret MG, Kupiecki FP, Wyse BM 1974 Epididymal fat pad alterations in mice with spontaneous obesity and diabetes and with chemically induced obesity. Diabetologia 10:639-648
33. Apovian CM, Bigornia S, Mott M, Meyers MR, Ulloor J, Gagua M, McDonnell M, Hess D, Joseph L, Gokce N 2008 Adipose macrophage infiltration is associated with insulin resistance and vascular endothelial dysfunction in obese subjects. Arterioscler Thromb Vasc Biol 28:1654-1659
34. Ruan H, Hacohen N, Golub TR, Van Parijs L, Lodish HF 2002 Tumor necrosis factor-α suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes: nuclear factor-κB activation by TNF-α is obligatory. Diabetes 51: 1319-1336 (Pubitemid 34826596)
35. Barnes PJ, Karin M 1997 Nuclear factor-αB. A pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336:1066-1071 (Pubitemid 27163860)
36. Ortego M, Bustos C, Hernández-Presa MA, Tuñón J, Díaz C, Hernández G, Egido J 1999 Atorvastatin reduces NF-κB activation and chemokine expression in vascular smooth muscle cells and mononuclear cells. Atherosclerosis 147:253-261 (Pubitemid 29512257)
37. Chen X, Andresen1 BT, Hill M, Zhang J, Booth F, Zhang C 2008 Role of reactive oxygen species in tumor necrosis factor-α induced endothelial dysfunction. Curr Hypertens Rev 4:245-255
38. Caballero AE, Arora S, Saouaf R, Lim SC, Smakowski P, Park JY, King GL, LoGerfo FW, Horton ES, Veves A 1999 Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes. Diabetes 48:1856-1862 (Pubitemid 29415208)
39. Hsueh WA, Quinones M, Creager MA 1997 Endothelium in insulin resistance and diabetes. Diabetes Rev 5:343-352 (Pubitemid 28033521)
40. Kanazawa K, Kawashima S, Mikami S, Miwa Y, Hirata K, Suematsu M, Hayashi Y, Itoh H, Yokoyama M 1996 Endothelial constitutive nitric oxide synthase protein and mRNA increased in rabbit atherosclerotic aorta despite impaired endothelium-dependent vascular relaxation. Am J Pathol 148:1949-1956 (Pubitemid 26170519)
41. Barua RS, Ambrose JA, Srivastava S, DeVoe MC, Eales-Reynolds LJ 2003 Reactive oxygen species are involved in smoking-induced dysfunction of nitric oxide biosynthesis and upregulation of endothelial nitric oxide synthase: an in vitro demonstration in human coronary artery endothelial cells. Circulation 107:2342-2347 (Pubitemid 36578506)
42. Li H, Wallerath T, Münzel T, Förstermann U 2002 Regulation of endothelial-type NO synthase expression in pathophysiology and in response to drugs. Nitric Oxide 7:149-164 (Pubitemid 35346221)
43. Oemar BS, Tschudi MR, Godoy N, Brovkovich V, Malinski T, Lüscher TF 1998 Reduced endothelial nitric oxide synthase expression and production in human atherosclerosis. Circulation 97: 2494-2498 (Pubitemid 28294493)
44. Duncan ER, Walker SJ, Ezzat VA, Wheatcroft SB, Li JM, Shah AM, Kearney MT 2007 Accelerated endothelial dysfunction in mild prediabetic insulin resistance: the early role of reactive oxygen species. Am J Physiol Endocrinol Metab 293:E1311-E1319 (Pubitemid 350106599)
45. Lund DD, Chu Y, Miller JD, Heistad DD 2009 Protective effect of extracellular superoxide dismutase on endothelial function during aging. Am J Physiol Heart Circ Physiol 296:H1920-H1925
46. Ohashi M, Runge MS, Faraci FM, Heistad DD 2006 MnSOD deficiency increases endothelial dysfunction in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 26:2331-2336 (Pubitemid 44465730)
47. Hotamisligil GS, Budavari A, Murray D, Spiegelman BM 1994 Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-α. J Clin Invest 94: 1543-1549
48. Ruan H, Lodish HF 2003 Insulin resistance in adipose tissue: direct and indirect effects of tumor necrosis factor-α. Cytokine Growth Factor Rev 14:447-455 (Pubitemid 37099456)
49. Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS 1997 Protection from obesity-induced insulin resistance in mice lacking TNF-α function. Nature 389:610-614 (Pubitemid 27446179)
50. Takano M, Nishihara R, Sugano N, Matsumoto K, Yamada Y, Takane M, Fujisaki Y, Ito K 2010 The effect of systemic anti-tumor necrosis factor-α treatment on Porphyromonas gingivalis infection in type 2 diabetic mice. Arch Oral Biol 55:379-384
51. Yazdani-Biuki B, Stelzl H, Brezinschek HP, Hermann J, Mueller T, Krippl P, Graninger W, Wascher TC 2004 Improvement of insulin sensitivity in insulin resistant subjects during prolonged treatment with the anti-TNF-α antibody infliximab. Eur J Clin Invest 34:641-642 (Pubitemid 39331479)
52. Ohkita M, Takaoka M, Shiota Y, Nojiri R, Matsumura Y 2002 Nitric oxide inhibits endothelin-1 production through the suppression of nuclear factor κ B. Clin Sci (Lond) 103:68S-71S (Pubitemid 35007123)
53. Min JK, Kim YM, Kim SW, Kwon MC, Kong YY, Hwang IK, Won MH, Rho J, Kwon YG 2005 TNF-related activation-induced cytokine enhances leukocyte adhesiveness: induction of ICAM-1 and VCAM-1 via TNF receptor-associated factor and protein kinase C-dependent NF-κB activation in endothelial cells. J Immunol 175: 531-540 (Pubitemid 40884359)
54. Kruithof EK 2008 Regulation of plasminogen activator inhibitor type 1 gene expression by inflammatory mediators and statins. Thromb Haemost 100:969-975
55. Hou B, Eren M, Painter CA, Covington JW, Dixon JD, Schoenhard JA, Vaughan DE 2004 Tumor necrosis factor α activates the human plasminogen activator inhibitor-1 gene through a distal nuclear factor κB site. J Biol Chem 279:18127-18136 (Pubitemid 38623225)
56. Lowenstein CJ, Alley EW, Raval P, Snowman AM, Snyder SH, Russell SW, Murphy WJ 1993 Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon γ and lipopolysaccharide. Proc Natl Acad Sci USA 90:9730-9734 (Pubitemid 23315860)